Blackstone’s NantHealth NH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-32,562
Closed -$350K – 88
2019
Q3
$350K Hold
32,562
– – ﹤0.01% 68
2019
Q2
$257K Sell
32,562
-7,240
-18% -$73.7K ﹤0.01% 87
2019
Q1
$549K Hold
39,802
– – ﹤0.01% 70
2018
Q4
$322K Hold
39,802
– – ﹤0.01% 50
2018
Q3
$937K Hold
39,802
– – ﹤0.01% 45
2018
Q2
$1.98M Hold
39,802
– – 0.01% 69
2018
Q1
$1.82M Hold
39,802
– – 0.01% 49
2017
Q4
$1.82M Hold
39,802
– – 0.01% 84
2017
Q3
$2.46M Hold
39,802
– – 0.02% 30
2017
Q2
$2.52M Hold
39,802
– – 0.02% 32
2017
Q1
$2.96M Hold
39,802
– – 0.02% 33
2016
Q4
$5.94M Hold
39,802
– – 0.04% 29
2016
Q3
$7.85M Hold
39,802
– – 0.05% 62
2016
Q2
$7.46M Buy
+39,802
New +$8.67M 0.03% 83

Other funds holding NH

Blackstone's NH Position: Q4 2019 in Review

Blackstone sold out of NantHealth (NH) in Q4 2019, closing a stake of 32,562 shares — an estimated $350K sold.

Blackstone first reported a position in NH in Q2 2016 and held it in 14 quarters. The position peaked at $7.85M in Q3 2016. 25 funds tracked by Wall St. Rank hold NH as of Q4 2019.

  • Blackstone reported no remaining NantHealth position as of Q4 2019 after selling out during the quarter.
  • Blackstone sold 32,562 NantHealth shares in Q4 2019, an estimated $350K.
  • Blackstone first reported a position in NantHealth in Q2 2016 and held it in 14 quarters.
  • Blackstone's NantHealth position peaked at $7.85M in Q3 2016.
  • 25 funds tracked by Wall St. Rank held NantHealth as of Q4 2019.

Based on Blackstone's 13F filing for Q4 2019, filed 14 Feb 2020.